A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read more at straitstimes.com.
Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...
AZoNano on MSN1d
New Adhesive Patch for Drug DeliveryA study reveals a novel adhesive patch prototype using AgNP-Cx+ for enhanced anti-tumor activity against melanoma, showcasing ...
Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...
Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...
A new study published in Drug Design, Development and Therapy suggests that cannabidiol (CBD) may help protect the heart from ...
AVA6000 consists of a chemotherapy drug, doxorubicin, bound to a linker that is cleaved by FAP. Because FAP is overexpressed in some tumor microenvironments, the linker may keep doxorubicin bound ...
A MAP (methotrexate, doxorubicin and cisplatin) chemotherapy regimen is currently used for the condition, though this treatment typically comes with poor outcomes. OS Therapies Chief Medical and ...
Supporters of devoted sarcoma awareness campaigner Darell McDonald say he leaves a powerful legacy following his death at 44 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback